Pharmaceutical Business Review
Anonymous User | Login

Orexo Confirms Meda Launch Of Edluar In The US

Published: 18-Aug-2009

Meda acquired commercialization rights for Edluar from Orexo in 2008

Orexo has confirmed that Meda has initiated the launch of the drug Edluar in the US. The launch follows the US Food and Drug Administration’s approval in March this year of Edluar 5mg and 10mg sublingual tablets for the short-term treatment of insomnia characterized by difficulties with sleep initiation.

The company said that Meda acquired exclusive worldwide commercialization rights for Edluar from Orexo in 2008. Orexo will receive royalty payments on Meda’s sales of Edluar in the US.

Torbjorn Bjerke, CEO of Orexo, said: “Edluar offers insomnia sufferers a convenient and effective treatment and Meda is well placed to sell Edluar in the US market.”

Reportedly, Edluar is a fast-acting, sublingual formulation of zolpidem. It is based on Orexo’s sublingual technology, involving a tablet placed under the tongue for fast and effective absorption of the active ingredient across the oral mucosa.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Solutions4Science

Temperature Mapping and Validation Services ...

Exploristics

Innovative Analysis Solutions for Data Exploration, Pharmacogenetics, Biomarkers and Exploratory Sta...

NeuroProof

Screening Services for Pre-Clinical Development of Neuro-Pharmaceuticals and Safety Pharmacology ...

DASGIP

Parallel Bioreactor Systems for the Cultivation of Bacterial, Phototrophic, Animal and Human Cells ...

BioKinetic Europe

Phase I/II Contract Research Organisation ...

Toxikon Europe

CRO Providing Preclinical Safety Studies for the Life Science Community ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GRACO's New FDA Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New Hydra-Clean

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New 1590 & 3150 Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Customer Testimonial – Astra Zeneca

From the control room to the downstream processing area and with an eye on utilities servi ...

Hygienic Processing

From the control room to the downstream processing area and with an eye on utilities servi ...

Related Companies

No items to display

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address